Back

O-GlcNAc transferase regulates H2O2 production via p38 MAPK

Jones, L. I.; Vang, S.; McIntire-Ray, H. J.; Petersen, H. A.; Morales, A. N.; Acevedo Rua, V. E.; Anderson, J. C.; Gonzalez Coba, A. J.; Krick, S.; Barnes, J. W.

2026-05-31 molecular biology
10.64898/2026.05.27.728188 bioRxiv
Show abstract

i.Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease characterized by augmented transforming growth factor-{beta} (TGF-{beta}) signaling leading to excessive extracellular matrix (ECM) deposition. The fibroblast-to-myofibroblast-transition (FMT) and metabolic reprogramming of lung fibroblasts (HLFs) are essential to IPF pathogenesis, yet the connection between nutrient metabolism and fibrogenesis remains poorly defined. The O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT) is a nutrient-sensitive enzyme that adds O-GlcNAc moieties to substrates. We previously showed that loss of OGT reverses bleomycin-induced pulmonary fibrosis in mice. Here, using unbiased kinomics, we show that pharmacologic inhibition of OGT suppressed non-canonical TGF-{beta}-induced mitogen-activated protein kinase (MAPK) signaling. Molecular confirmation revealed that TGF-{beta}-induced phosphorylation of p38, but not ERK or JNK, was reduced by OGT blockade. Furthermore, p38 itself was O-GlcNAc-modified, which enhanced its phosphorylation and promoted downstream phosphorylation of the NADPH oxidase subunit, p47phox. Inhibition of OGT, p38, or p47phox reduced reactive oxygen species (ROS) in HLFs, revealing a previously unknown role of OGT-p38-p47phox signaling in ROS production. Collectively, this work establishes that O-GlcNAc-modified p38 enhances p47phox-dependent H2O2 production. HighlightsO_LIUsing PamChip STK arrays, we show that OGT inhibition causes broad kinomic remodeling, including suppression of non-canonical TGF-{beta} MAPKs and multiple CDKs. C_LIO_LIOGT blockade selectively attenuates p38 phosphorylation, despite TGF-{beta}-induced substrate redundancy with ERK and JNK. C_LIO_LIWe provide evidence that p38 MAPK undergoes O-GlcNAcylation in human lung fibroblasts, a modification not previously reported. C_LIO_LIThe study identifies a new signaling axis where O-GlcNAc modification of p38 modulates the phosphorylation of p47phox, therefore regulating NOX-dependent H2O2 production. C_LIO_LIBlocking OGT or inhibiting p38/p47phox dramatically reduces TGF-{beta}-driven H2O2 production in human lung fibroblasts. C_LI Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=143 SRC="FIGDIR/small/728188v1_ufig1.gif" ALT="Figure 1"> View larger version (28K): org.highwire.dtl.DTLVardef@1da33c7org.highwire.dtl.DTLVardef@7d8001org.highwire.dtl.DTLVardef@15ee0adorg.highwire.dtl.DTLVardef@1f0a89d_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Redox Biology
70 papers in training set
Top 0.1%
22.7%
2
Cell Reports
1498 papers in training set
Top 3%
8.0%
3
JCI Insight
277 papers in training set
Top 0.6%
6.8%
4
American Journal of Respiratory Cell and Molecular Biology
43 papers in training set
Top 0.2%
4.9%
5
Nature Communications
5641 papers in training set
Top 30%
4.4%
6
The EMBO Journal
309 papers in training set
Top 2%
3.3%
50% of probability mass above
7
Journal of the American Chemical Society
217 papers in training set
Top 1.0%
3.3%
8
European Respiratory Journal
59 papers in training set
Top 0.3%
3.3%
9
Circulation Research
47 papers in training set
Top 0.6%
2.5%
10
eLife
5828 papers in training set
Top 40%
2.4%
11
Science Signaling
65 papers in training set
Top 0.4%
2.4%
12
Advanced Science
286 papers in training set
Top 4%
1.8%
13
Molecular Cell
350 papers in training set
Top 3%
1.7%
14
The FASEB Journal
194 papers in training set
Top 3%
1.7%
15
ACS Chemical Biology
167 papers in training set
Top 2%
1.5%
16
Journal of Biological Chemistry
690 papers in training set
Top 6%
1.4%
17
EMBO Reports
263 papers in training set
Top 4%
1.4%
18
iScience
1154 papers in training set
Top 29%
1.1%
19
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 38%
1.0%
20
EMBO Molecular Medicine
95 papers in training set
Top 2%
1.0%
21
PLOS Pathogens
820 papers in training set
Top 8%
1.0%
22
Arteriosclerosis, Thrombosis, and Vascular Biology
71 papers in training set
Top 1%
0.9%
23
Cell Stem Cell
62 papers in training set
Top 2%
0.9%
24
Journal of Clinical Investigation
179 papers in training set
Top 5%
0.9%
25
eBioMedicine
183 papers in training set
Top 6%
0.9%
26
Journal of Translational Medicine
57 papers in training set
Top 3%
0.6%
27
PLOS ONE
5266 papers in training set
Top 64%
0.6%